Minerco Inc. (MINE): mmmm The aroma of a freshly printed PR m...

Home > Boards > US OTC > Medical - Psychedelics > Minerco Inc. (MINE)

Followed By	71
Posts	2592
Boards Moderated	0
Alias Born	02/09/2012

The Hook

Wednesday, June 04, 2014 4:12:55 PM

Re: StockScout1 post# 154685

mmmm The aroma of a freshly printed PR may tickle some taste buds, Early Tomorrow Morning...Better have some MINE Coffee Boost on hand.:) :) :)...EARLY AM :) :) just in case...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation

Molecular Data Inc. Announces ADS Ratio Change
Mullen Announces Hiring of Richard Curtis to President of International Operations
Getlink: ElecLink Goes Live and Looks Forward to Its First Auctions
Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE MultiStem Ischemic Stroke Study
Deere & Company Down Over 10%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Ross Stores Down Over 21%, on Track for Largest Percent Decrease Since December 1993 -- Data Talk
Macellum Issues Statement Regarding the Kohl’s Board’s Apparent Breach of Fiduciary Duty and Failure to Disclose Material Information Prior to 2022 Annual Meeting
Jakubowitz Law Reminds Upstart Shareholders of a Lead Plaintiff Deadline of July 12, 2022
Richemont Shares Fall After Fiscal Year Operating Profit Missed Views, No Resolution Regarding YNAP
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold as YONDELIS ® by Janssen, a Johnson & Johnson Company) in Connective Tissue Cancer Soft Tissue Sarcoma Mice Study
Bank of America Announces 2023 Financial Reporting Dates
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®
Foghorn Therapeutics Shares Down After FDA Partial Clinical Hold
Evofem Biosciences Announces Pricing of Approximately $26.6 Million Public Offering
AMD Chair and CEO Dr. Lisa Su to Keynote at COMPUTEX 2022
BAE Systems’ New CV90 Combat Support Vehicles Delivered to Norway
FTSE 100 Closes Friday Up on China Overnight Rate Cut
Top Company News of the Day
Top Company News of the Day

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Detailed Quote